查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1904590

腸道健康和益生菌食品市場預測至2032年：按產品類型、益生菌菌株、劑型、分銷管道、最終用戶和地區分類的全球分析

Gut Health & Probiotic Foods Market Forecasts to 2032 - Global Analysis By Product Type, Probiotic Strain, Form, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計到 2025 年，全球腸道健康和益生菌食品市場價值將達到 803.9 億美元，到 2032 年將達到 1,308 億美元，在預測期內的複合年成長率為 7.2%。

腸道健康和益生菌食品是一種旨在透過維持腸道微生物的健康平衡來改善消化器官系統的膳食補充劑。這些產品富含活性有益菌、膳食纖維和功能性成分，能夠滋養腸道生態系。持續食用有助於改善消化、增強免疫反應、有效吸收營養並預防胃腸道不適。透過支持微生物多樣性和腸道健康，這些食品在促進長期健康和預防消化系統疾病方面發揮重要作用。

消化系統疾病呈上升趨勢

消費者越來越意識到腸道菌叢在整體健康中的作用，這推動了富含益生菌的機能性食品的普及。診斷工具的進步正在識別更多消化失衡的人群，進一步擴大了消費群。人口老化和久坐的生活方式也導致全球消化系統併發症率的上升。醫學專家建議將富含益生菌的飲食作為預防和治療措施。人們對整體健康和自然療法的日益關注，進一步凸顯了腸道健康解決方案的重要性。因此，益生菌食品正逐漸成為主流，既作為膳食補充劑，也作為日常消費品。

研發和生產高成本

為了確保產品質量，製造商必須投資先進的發酵技術和可控的生產環境。此外，由於益生菌食品必須符合多個地區的嚴格安全和標籤標準，因此合規性也會帶來額外的成本。小規模公司往往由於缺乏專業設備和技術而難以參與競爭。高昂的生產成本導致產品定價偏高，這可能會限制價格敏感型消費者的購買力。如何在擴大生產規模的同時保持活性菌群的存活率，仍然是一項技術挑戰。

個人化營養與人工智慧

人工智慧驅動的平台能夠根據個人的微生物組特徵提供個人化的飲食建議。消費者越來越傾向於尋求能夠解決特定消化器官系統問題和實現特定健康目標的客製化解決方案。數據分析技術和穿戴式健康設備的進步使得將益生菌融入個人化飲食計劃成為可能。企業正在利用機器學習來預測消費者偏好並最佳化產品開發。這種技術與營養的融合正在推動消費者參與度和忠誠度的提升。隨著個人化成為現代健康理念的標誌，益生菌食品有望從中受益匪淺。

與製藥解決方案的競爭

與飲食療法相比，處方藥通常能更快緩解症狀。針對微生物組的藥物開發平臺不斷擴展，對益生菌食品的廣泛普及構成了直接挑戰。消費者可能認為，如果藥物有實驗室檢測支持或由醫生推薦，則更值得信賴。醫療保險對醫療程序的涵蓋進一步增強了藥物相對於食品類替代品的優勢。益生菌生產商必須透過強調預防保健和長期益處來使產品脫穎而出。

新冠疫情的影響

疫情改變了消費者的關注重點，免疫力和腸道健康比以往任何時候都更加受到重視。封鎖導致的供應鏈中斷使得多個地區的益生菌產品供不應求。然而，健康意識的提高也帶動了對增強抵抗力和促進健康的機能性食品的需求。在出行限制期間，線上零售通路對於維持產品供應至關重要。製造商加快了數位化行銷宣傳活動，以教育消費者了解腸道健康與免疫力之間的關聯。監管機構也推出了臨時性的彈性措施，以確保消費者能夠持續獲得必需的益生菌補充劑。疫情後，益生菌食品公司的策略重點是增強市場韌性、拓展電子商務以及實現採購多元化。

預計在預測期內，乳酸菌細分市場將佔據最大的市場佔有率。

由於乳酸菌在乳製品、飲料和膳食補充劑等領域的廣泛應用，預計在預測期內，乳酸菌細分市場將佔據最大的市場佔有率。大量文獻證實，乳酸菌菌株能夠改善消化功能並增強免疫功能。其穩定性以及與各種食品基質的相容性使其用途廣泛。消費者透過優格等傳統產品熟悉乳酸菌，增強了消費者對其的信任和接受度。持續的研究不斷證實乳酸菌在治療胃腸道疾病和促進整體健康方面的有效性。製造商正在投資開發膠囊、粉末和強化零食等創新產品形式。

預計在預測期內，線上零售/電子商務領域的複合年成長率將最高。

預計在預測期內，線上零售/電子商務領域將保持最高的成長率。電子商務平台為消費者提供了便利的管道，讓他們能夠購買到種類繁多的益生菌產品。數位化管道支援個人化推薦和訂閱模式，從而提高了客戶維繫。疫情加速了消費者向網路購物的轉變，並帶來了持久的行為改變。企業正利用社群媒體和網紅行銷來提升品牌知名度和信譽度。提供透明化服務和客製化產品組合的直接面對消費者（D2C）品牌正在崛起。隨著數位生態系統的擴展，線上零售預計仍將是益生菌食品領域最具活力的驅動力。

比最大的地區

預計亞太地區將在預測期內佔據最大的市場佔有率。中國、印度和日本等國家擁有悠久的發酵食品傳統，有助於益生菌在當地文化中被廣泛接受。可支配收入的成長和都市化正在推動該地區對機能性食品的需求。各國政府正大力進行健康宣傳宣傳活動，並專注於營養和預防性醫療保健。當地製造商正在擴大產能以滿足不斷成長的國內需求。與全球企業的策略合作正在加速技術轉移和創新。

複合年均成長率最高的地區

預計中東和非洲地區在預測期內將實現最高的複合年成長率。人們對文明病的日益關注推動了功能性營養的發展。西式飲食習慣在都市區日益盛行，進而催生了益生菌強化產品的需求。本地產能有限導致進口增加，國際品牌也隨之滲透。各國政府增加對醫療基礎設施和健康促進措施的投資，間接促進了益生菌的廣泛應用。線上零售平台的快速擴張，提高了服務不足市場的可近性。

免費客製化服務訊息

購買此報告的客戶可享有以下免費自訂選項之一：

  • 公司概況
    • 最多三家新增市場參與企業進行全面分析
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，對主要國家進行市場估算和預測，並計算複合年成長率（註：可行性需確認）。
  • 競爭標竿分析
    • 從產品系列、地域覆蓋範圍和策略聯盟等方面對主要參與企業進行基準分析

目錄

第1章執行摘要

第2章 前言

  • 摘要
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球腸道健康與益生菌食品市場（依產品類型分類）

  • 乳製品益生菌食品
  • 非乳製品/植物來源益生菌食品
  • 發酵食品
  • 機能飲料
  • 腸道健康補充劑
  • 其他

6. 全球腸道環境與益生菌食品市場（依益生菌菌株分類）

  • 乳酸菌
  • 雙歧桿菌
  • 布氏酵母
  • 其他

7. 全球腸道環境與益生菌食品市場（按類型分類）

  • 液體
  • 粉末
  • 膠囊和片劑
  • 食品添加物

8. 全球腸道健康與益生菌食品市場（依分銷管道分類）

  • 超級市場/大賣場
  • 藥房和藥品商店
  • 健康食品和特色商店
  • 直接面對消費者的品牌
  • 線上零售/電子商務

9. 全球腸道健康和益生菌食品市場（按最終用戶分類）

  • 成人
  • 兒童
  • 老年人
  • 臨床和醫療應用
  • 其他

第10章 全球腸道健康與益生菌食品市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章：企業概況

  • Nestle SA
  • Valio Ltd.
  • Danone SA
  • Probi AB
  • Yakult Honsha Co., Ltd.
  • Sanofi SA
  • Chr. Hansen Holding A/S
  • Amway Corporation
  • DuPont
  • Kerry Group plc
  • PepsiCo, Inc.
  • BioGaia AB
  • General Mills, Inc.
  • Lallemand Inc.
  • Arla Foods amba
Product Code: SMRC33130

According to Stratistics MRC, the Global Gut Health & Probiotic Foods Market is accounted for $80.39 billion in 2025 and is expected to reach $130.80 billion by 2032 growing at a CAGR of 7.2% during the forecast period. Gut Health & Probiotic Foods are nutrition-based products designed to enhance digestive system functionality by maintaining a healthy balance of intestinal microbes. They are enriched with live beneficial bacteria, supportive fibers, and functional ingredients that nourish the gut ecosystem. Consistent intake aids in better digestion, improved immune response, efficient nutrient uptake, and protection against gastrointestinal imbalances. By supporting microbial diversity and gut integrity, these foods play a vital role in promoting long-term health and preventing digestive-related ailments.

Market Dynamics:

Driver:

Increasing prevalence of GI disorders

Consumers are increasingly aware of the role gut microbiota plays in overall health, driving adoption of functional foods enriched with probiotics. As diagnostic tools improve, more individuals are being identified with digestive imbalances, further expanding the consumer base. Aging populations and sedentary lifestyles are also contributing to higher rates of GI complications worldwide. Probiotic-rich diets are being promoted by healthcare professionals as preventive and therapeutic measures. The growing emphasis on holistic wellness and natural remedies is reinforcing the importance of gut health solutions. Consequently, probiotic foods are becoming mainstream as both dietary supplements and everyday consumables.

Restraint:

High Costs of R&D and production

Manufacturers must invest in advanced fermentation technologies and controlled environments to maintain product quality. Regulatory compliance adds further expense, as probiotic foods must meet stringent safety and labeling standards across multiple regions. Smaller firms often struggle to compete due to limited access to specialized equipment and expertise. High production costs can lead to premium pricing, restricting accessibility for price-sensitive consumers. Scaling up production while maintaining live culture viability remains a technical challenge.

Opportunity:

Personalized nutrition & AI

AI-driven platforms are enabling tailored dietary recommendations based on individual microbiome profiles. Consumers are increasingly seeking customized solutions that address specific digestive issues or wellness goals. Advances in data analytics and wearable health devices are supporting the integration of probiotics into personalized diet plans. Companies are leveraging machine learning to predict consumer preferences and optimize product development. This convergence of technology and nutrition is fostering greater consumer engagement and loyalty. As personalization becomes a hallmark of modern wellness, probiotic foods are positioned to benefit significantly.

Threat:

Competition from pharmaceutical solutions

Prescription medications often provide faster symptom relief compared to dietary interventions. The growing pipeline of microbiome-targeted drugs poses a direct challenge to probiotic food adoption. Consumers may perceive pharmaceuticals as more reliable due to clinical trial backing and physician endorsements. Insurance coverage for medical treatments further tilts the balance against food-based alternatives. Probiotic manufacturers must differentiate their offerings by emphasizing preventive health and long-term benefits.

Covid-19 Impact:

The pandemic reshaped consumer priorities, with immunity and gut health gaining unprecedented attention. Lockdowns disrupted supply chains, leading to shortages of probiotic products in several regions. However, heightened health awareness boosted demand for functional foods that support resilience and recovery. Online retail channels became critical in maintaining product availability during restricted physical movement. Manufacturers accelerated digital marketing campaigns to educate consumers about the link between gut health and immunity. Regulatory agencies introduced temporary flexibilities to ensure continued access to essential probiotic supplements. Post-pandemic strategies now emphasize resilience, e-commerce expansion, and diversified sourcing for probiotic food companies.

The lactobacillus segment is expected to be the largest during the forecast period

The lactobacillus segment is expected to account for the largest market share during the forecast period, due to its widespread application in dairy, beverages, and supplements. Lactobacillus strains are well-documented for improving digestion and enhancing immune function. Their stability and compatibility with multiple food matrices make them highly versatile. Consumers are familiar with lactobacillus through traditional products like yogurt, which reinforces trust and adoption. Ongoing research continues to validate their efficacy in managing GI disorders and promoting overall wellness. Manufacturers are investing in innovative delivery formats such as capsules, powders, and fortified snacks.

The online retail/E-commerce segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the online retail/E-commerce segment is predicted to witness the highest growth rate. E-commerce platforms provide consumers with convenient access to a wide range of probiotic products. Digital channels enable personalized recommendations and subscription models, enhancing customer retention. The pandemic accelerated the shift toward online shopping, creating lasting behavioral changes. Companies are leveraging social media and influencer marketing to boost visibility and trust. Direct-to-consumer brands are thriving by offering transparency and tailored product bundles. As digital ecosystems expand, online retail will remain the most dynamic growth driver for probiotic foods.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share. Countries like China, India, and Japan have strong traditions of fermented foods, supporting cultural acceptance of probiotics. Rising disposable incomes and urbanization are increasing demand for functional foods in the region. Governments are promoting health awareness campaigns that emphasize nutrition and preventive care. Local manufacturers are expanding production capacity to meet growing domestic demand. Strategic partnerships with global players are accelerating technology transfer and innovation.

Region with highest CAGR:

Over the forecast period, the Middle East & Africa region is anticipated to exhibit the highest CAGR. Rising awareness of lifestyle-related diseases is driving interest in functional nutrition. Urban populations are increasingly adopting Western dietary habits, creating demand for probiotic-enriched products. Limited local production capacity is encouraging imports and international brand penetration. Governments are investing in healthcare infrastructure and wellness initiatives, indirectly supporting probiotic adoption. Online retail platforms are expanding rapidly, improving accessibility in underserved markets.

Key players in the market

Some of the key players in Gut Health & Probiotic Foods Market include Nestle S.A., Valio Ltd., Danone S.A., Probi AB, Yakult Honsha Co., Ltd., Sanofi S.A., Chr. Hansen Holding A/S, Amway Corporation, DuPont de Nemours, Inc., Kerry Group plc, PepsiCo, Inc., BioGaia AB, General Mills, Inc., Lallemand Inc., and Arla Foods.

Key Developments:

In September 2025, DuPont has signed an agreement to acquire Sinochem (Ningbo) RO Memtech Co., Ltd. to expand its reverse osmosis (RO) manufacturing footprint into China and the Asia Pacific region. With advanced membrane and fabrication production technologies, the acquisition increases DuPont's capacity to meet the growing demand in the region for FilmTec(TM) elements for industrial water purification and reuse.

In September 2025, Danone announced the inauguration of its OneBiome Laboratory in Paris-Saclay, marking a major milestone in its commitment to science-based innovation and leadership in gut health research. The Danone OneBiome Lab will serve as a global hub for microbiome science, nutrition, and digital health, reinforcing Danone's pioneering role in shaping the future of food and health.

Product Types Covered:

  • Dairy-based Probiotic Foods
  • Non-dairy/Plant-based Probiotic Foods
  • Fermented Foods
  • Functional Beverages
  • Gut Health Supplements
  • Other Product Types

Probiotic Strains Covered:

  • Lactobacillus
  • Bifidobacterium
  • Saccharomyces boulardii
  • Other Emerging Strains

Forms Covered:

  • Liquid
  • Powder
  • Capsule/Tablets
  • Food Additives

Distribution Channels Covered:

  • Supermarkets/Hypermarkets
  • Pharmacies & Drug Stores
  • Health & Specialty Stores
  • Direct-to-Consumer Brands
  • Online Retail/E-commerce

End Users Covered:

  • Adults
  • Children
  • Elderly Population
  • Clinical/Medical Use
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gut Health & Probiotic Foods Market, By Product Type

  • 5.1 Introduction
  • 5.2 Dairy-based Probiotic Foods
  • 5.3 Non-dairy/Plant-based Probiotic Foods
  • 5.4 Fermented Foods
  • 5.5 Functional Beverages
  • 5.6 Gut Health Supplements
  • 5.7 Other Product Types

6 Global Gut Health & Probiotic Foods Market, By Probiotic Strain

  • 6.1 Introduction
  • 6.2 Lactobacillus
  • 6.3 Bifidobacterium
  • 6.4 Saccharomyces boulardii
  • 6.5 Other Emerging Strains

7 Global Gut Health & Probiotic Foods Market, By Form

  • 7.1 Introduction
  • 7.2 Liquid
  • 7.3 Powder
  • 7.4 Capsule/Tablets
  • 7.5 Food Additives

8 Global Gut Health & Probiotic Foods Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Supermarkets/Hypermarkets
  • 8.3 Pharmacies & Drug Stores
  • 8.4 Health & Specialty Stores
  • 8.5 Direct-to-Consumer Brands
  • 8.6 Online Retail/E-commerce

9 Global Gut Health & Probiotic Foods Market, By End User

  • 9.1 Introduction
  • 9.2 Adults
  • 9.3 Children
  • 9.4 Elderly Population
  • 9.5 Clinical/Medical Use
  • 9.6 Other End Users

10 Global Gut Health & Probiotic Foods Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Nestle S.A.
  • 12.2 Valio Ltd.
  • 12.3 Danone S.A.
  • 12.4 Probi AB
  • 12.5 Yakult Honsha Co., Ltd.
  • 12.6 Sanofi S.A.
  • 12.7 Chr. Hansen Holding A/S
  • 12.8 Amway Corporation
  • 12.9 DuPont
  • 12.10 Kerry Group plc
  • 12.11 PepsiCo, Inc.
  • 12.12 BioGaia AB
  • 12.13 General Mills, Inc.
  • 12.14 Lallemand Inc.
  • 12.15 Arla Foods amba

List of Tables

  • Table 1 Global Gut Health & Probiotic Foods Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Gut Health & Probiotic Foods Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Gut Health & Probiotic Foods Market Outlook, By Dairy-based Probiotic Foods (2024-2032) ($MN)
  • Table 4 Global Gut Health & Probiotic Foods Market Outlook, By Non-dairy/Plant-based Probiotic Foods (2024-2032) ($MN)
  • Table 5 Global Gut Health & Probiotic Foods Market Outlook, By Fermented Foods (2024-2032) ($MN)
  • Table 6 Global Gut Health & Probiotic Foods Market Outlook, By Functional Beverages (2024-2032) ($MN)
  • Table 7 Global Gut Health & Probiotic Foods Market Outlook, By Gut Health Supplements (2024-2032) ($MN)
  • Table 8 Global Gut Health & Probiotic Foods Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 9 Global Gut Health & Probiotic Foods Market Outlook, By Probiotic Strain (2024-2032) ($MN)
  • Table 10 Global Gut Health & Probiotic Foods Market Outlook, By Lactobacillus (2024-2032) ($MN)
  • Table 11 Global Gut Health & Probiotic Foods Market Outlook, By Bifidobacterium (2024-2032) ($MN)
  • Table 12 Global Gut Health & Probiotic Foods Market Outlook, By Saccharomyces boulardii (2024-2032) ($MN)
  • Table 13 Global Gut Health & Probiotic Foods Market Outlook, By Other Emerging Strains (2024-2032) ($MN)
  • Table 14 Global Gut Health & Probiotic Foods Market Outlook, By Form (2024-2032) ($MN)
  • Table 15 Global Gut Health & Probiotic Foods Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 16 Global Gut Health & Probiotic Foods Market Outlook, By Powder (2024-2032) ($MN)
  • Table 17 Global Gut Health & Probiotic Foods Market Outlook, By Capsule/Tablets (2024-2032) ($MN)
  • Table 18 Global Gut Health & Probiotic Foods Market Outlook, By Food Additives (2024-2032) ($MN)
  • Table 19 Global Gut Health & Probiotic Foods Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 20 Global Gut Health & Probiotic Foods Market Outlook, By Supermarkets/Hypermarkets (2024-2032) ($MN)
  • Table 21 Global Gut Health & Probiotic Foods Market Outlook, By Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 22 Global Gut Health & Probiotic Foods Market Outlook, By Health & Specialty Stores (2024-2032) ($MN)
  • Table 23 Global Gut Health & Probiotic Foods Market Outlook, By Direct-to-Consumer Brands (2024-2032) ($MN)
  • Table 24 Global Gut Health & Probiotic Foods Market Outlook, By Online Retail/E-commerce (2024-2032) ($MN)
  • Table 25 Global Gut Health & Probiotic Foods Market Outlook, By End User (2024-2032) ($MN)
  • Table 26 Global Gut Health & Probiotic Foods Market Outlook, By Adults (2024-2032) ($MN)
  • Table 27 Global Gut Health & Probiotic Foods Market Outlook, By Children (2024-2032) ($MN)
  • Table 28 Global Gut Health & Probiotic Foods Market Outlook, By Elderly Population (2024-2032) ($MN)
  • Table 29 Global Gut Health & Probiotic Foods Market Outlook, By Clinical/Medical Use (2024-2032) ($MN)
  • Table 30 Global Gut Health & Probiotic Foods Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.